EOM Pharmaceuticals Holdings, Inc. (IMUC) Research

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medications. These treatments hold the potential to revolutionize existing therapeutic approaches. Among its key drug candidates currently undergoing development are EOM613 and EOM147. Established on March 20, 1987, the company maintains its corporate headquarters in Montvale, New Jersey.

Market snapshot

Symbol
IMUC
Price
$0.21
Day change
-22.19%
Market cap
$23.8M
P/E ratio
-13.82x
52-week range
0.036-0.34
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Devonian Health Group Inc. (DVHGF)
  • Hemostemix Inc. (HMTXF)
  • HOOKIPA Pharma Inc. (HOOK)
  • Algorae Pharmaceuticals Limited (LVCLF)
  • Nymox Pharmaceutical Corporation (NYMXF)
  • Oxford BioDynamics Plc (OXBOF)
  • Propanc Biopharma, Inc. (PPCB)
  • PreveCeutical Medical Inc. (PRVCF)

Recent insider activity

  • Yu John S — A-Award (120000 shares) on 2018-06-06
  • Gengos Andrew — F-InKind (3284 shares) on 2016-12-31
  • Yu John S — A-Award (156750 shares) on 2016-06-17
  • Titus Gary — A-Award (156750 shares) on 2016-06-17
  • Singhvi Rahul — A-Award (156750 shares) on 2016-06-17

Open EOM Pharmaceuticals Holdings, Inc. (IMUC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.